May 10, 2001

Monitoring the body's rhythms Researcher David Harper displays an activity monitor, below, and a mini-logger that measures temperature changes, which are both tools for his research on how biorhythms relate to Alzheimer's disease. Full story

HARVARD GAZETTE ARCHIVES

GAZETTE SPECIAL May 14, 2001
New drug dissolves stomach tumors
George Demetri and his colleagues have discovered a new drug that rapidly kills tumors in a once incurable type of stomach cancer. The same drug is also being tested against brain, lung, and prostate cancers.

Getting into rhythms of Alzheimer's disease
By clocking the biorhythms of older people, researchers have come up with a way to tell if a person has Alzheimer's disease. As new drugs and even a vaccine are developed for this personality-robbing disease, it becomes critically important to make sure these treatments are given to the right people.

Shaking up our love of salt
Panelists at a School of Public Health (SPH) symposium on May 3 said the best way to get Americans to eat less salt may be to silently cut the amount used in the chips and dips and TV dinners and other processed and ready-to-eat foods we all love.

Caffeine reduces risk of Parkinson's
In the first comprehensive examination of caffeine consumption from a variety of sources and the risk of developing Parkinson's disease, researchers from the Harvard School of Public Health (SPH) have determined that moderate consumption of caffeine reduces the risk of Parkinson's disease in men and women.

Copyright 2002 by the President and Fellows of Harvard College